GLP-1 medications like Ozempic and Mounjaro (which have been approved for treating type 2 diabetes but are sometimes used off-label for weight loss), as well as Wegovy and Zepbound (which have been approved to treat overweight and obesity), have soared in popularity due to their effectiveness as weight loss aids
"Ozempic (semaglutide) is a prescription medicine that should be taken under the care of a licensed healthcare provider." The rep said the drug is FDA-approved to treat type 2 diabetes to improve blood sugar and reduce the risk of cardiovascular events, adding, "Ozempic is not indicated for chronic weight management." Their statement continued, "The safety and efficacy profile of Ozempic has been evaluated in clinical studies involving more than patients
This hormone is called GLP-1 (glucagon-like peptide-1)
DPP, dipeptidyl peptidase
However, when antioxidative systems become saturated, RBCs accumulate oxidative lesions, provoking biochemical alterations and advancing pathological developments (Bardyn et al., 2018)